BioMarin Pharmaceutical (BMRN) Tops Q1 EPS by 11c, Guides Higher for FY Revs
Tweet Send to a Friend
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) reports Q1 non-GAAP EPS of $0.06, 11 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
